High-performance liquid chromatographic determination of mitoxantrone in plasma utilizing non-bonded silica gel for solid-phase isolation to reduce adsorptive losses on glass during sample preparation
- 1 January 1989
- journal article
- research article
- Published by Elsevier in Journal of Chromatography A
- Vol. 465 (2) , 75-86
- https://doi.org/10.1016/s0021-9673(01)83574-3
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- Mitoxantron determination using high-performance liquid chromatography: Improved sensitivity by loop-column injection for dual-dose pharmacokinetic studiesJournal of Chromatography B: Biomedical Sciences and Applications, 1988
- Direct determination of mitoxantrone and its mono- and dicarboxylic metabolites in plasma and urine by high-performance liquid chromatographyJournal of Chromatography B: Biomedical Sciences and Applications, 1988
- The pharmacokinetics and metabolism of mitoxantrone in manInvestigational New Drugs, 1985
- Pharmacology of mitoxantrone: mode of action and pharmacokineticsInvestigational New Drugs, 1985
- Disposition of mitoxantrone in patientsCancer Treatment Reviews, 1983
- Improved high-performance liquid chromatography of the new antineoplastic agents bisantrene and mitoxantroneJournal of Chromatography B: Biomedical Sciences and Applications, 1982
- Clinical kinetics of 1,4-dihydroxy-5,8-bis [[2- [(2-hydroxyethyl)amino ]ethyl] amino]-9,10-anthracenedioneClinical Pharmacology & Therapeutics, 1982
- CLINICAL AND CLINICAL PHARMACOLOGIC STUDIES OF MITOXANTRONE1982
- Clinical analysis for the anti-neoplastic agent 1,4-dihydroxy-5,8-bis{{2-[(2-hydroxyethyl)amino]ethyl}amino} 9,10-anthracenedione dihydrochloride (NSC 301739) in plasmaJournal of Chromatography B: Biomedical Sciences and Applications, 1981
- An HPLC Method for the Quantitative Determination of 1,4-Dihydroxy-5,8 Bis [[2-[(2-Hydroxyethyl) Amino] Ethyl] Amino] 9,10 - Anthracenedione (DHAQ, Lederle Labs CL232 315, NCS 301739) in SerumJournal of Liquid Chromatography, 1980